Академический Документы
Профессиональный Документы
Культура Документы
No. 11-2089
German
corporation,
Defendant - Appellee.
No. 11-2141
German
corporation,
Defendant - Appellant.
No. 12-1121
v.
ECKERT & ZIEGLER NUCLITEC GMBH,
successor to QSA Global GmbH,
German
corporation,
Defendant - Appellee.
Appeals from the United States District Court for the Eastern
District of Virginia, at Alexandria.
Claude M. Hilton, Senior
District Judge. (1:10-cv-00617-CMH-IDD)
Argued:
for
further
ARGUED:
James Michael Brady, BEST MEDICAL INTERNATIONAL, INC.,
Springfield, Virginia, for appellants.
Carl Dewayne Lonas,
MORAN, REEVES & CONN, PC, Richmond, Virginia, for appellee. ON
BRIEF: Matthew J. Hundley, MORAN, REEVES & CONN, PC, Richmond,
Virginia, for appellee.
PER CURIAM:
In 1999, a predecessor of Eckert & Ziegler Nuclitec
GmbH (referred to hereinafter, together with Eckert & Ziegler,
as
EZN)
entered
predecessor
Vascular,
of
into
Best
Inc.
Manufacturing
Medical
(referred
to
Agreement
International,
hereinafter,
with
the
Inc.
and
Best
together
with
Best
for
Best
strontium
90
sources.
Sources
are
of
therapy.
sources
welded
together
--
for
medical
radiation
and
decommission
the
production
line.
Best
also
Under
the
Settlement
Agreement,
Best
agreed
to
to
recover
costs
from
its
Best
costs
from
directly.
the
performance
bond
and
The
Settlement
Agreement
needed
to
be
disposed
of,
so
long
as
Best
was
not
in
ever
submitted
original
letter
of
credit
or
even
for
four
decontaminate
extensions
and
with
decommission
respect
the
to
its
production
obligation
line,
but
to
even
In January
2010, EZN told Best that it was undertaking the task, as it was
authorized to do by the Settlement Agreement.
In addition, even
though Best paid the required 100,000 for source trains and EZN
offered to ship Best the source trains it had in stock, Best
refused to accept those source trains, claiming that they did
not
meet
the
specifications
set
Manufacturing Agreement.
5
forth
in
the
original
It
production
line
in
the
course
of
decontaminating
and
the
performance
Agreement
Settlement
bond;
by
(2)
failing
Agreement
that
to
Best
by
failing
breached
decontaminate
and
to
the
post
Settlement
decommission
the
the
Settlement
Agreement;
and
(4)
that
EZN
should
be
district
the
parties
court
cross-motions
entered
judgment
for
on
summary
judgment,
September
7,
2011,
Best
Med.
Intl,
6
Inc.
v.
Eckert
&
Ziegler
Settlement
satisfy
the
availability
Agreement
Source
of
the
only
required
manufacturing
current
EZN
to
requirements
inventory.
Id.
at
attempt
to
based
on
*2-5.
In
although
Best
did
default
on
its
[decontamination
and
Id. at *5-7.
EZN and Best then each moved for attorneys fees and
costs, claiming to be the prevailing party entitled to that
award under the Settlement Agreement.
EZN
$14,845.70
Procedure
in
costs
54(d)(1).
taxable
EZN
under
Federal
explained
that
Rule
its
of
fee
Civil
request
its
fees
by
$38,255.60
to
account
for
prelitigation
that
the
timekeepers.
court
had
denied
as
untimely,
and
duplicate
concluding that the hours and rates were reasonable; that EZNs
10% discount to its lodestar was reasonable; and that there was
no need to further discount because of EZNs failure to prevail
on its counterclaim as there was no duplication involved over
and above the effort to defend itself.
This
appeal
followed,
with
both
parties
challenging
While
the
district
court
did
generally
recognize
manner,
stating,
Taking
the
Johnson
factors
into
account, the Court finds the hours expended and the rates billed
to be reasonable.
Accordingly,
judgment
on
the
we
merits
affirm
and
the
its
district
ruling
courts
that
EZN
summary
was
the